MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Chất ức chế kinase tyrosine
MedXY News
EnglishTag

Chất ức chế kinase tyrosine

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationcritical carebiomarkersartificial intelligencetype 1 diabetesclinical trialsHypertensiononcologyCardiologyMortalitypublic healthcardiovascular diseasediabetesAlzheimer's diseasebreast cancerepidemiology

Latest news

Tag

Ponatinib Plus Blinatumomab vs. Imatinib And Chemotherapy: Advancing Frontline Therapy in Adult Philadelphia-Positive ALL
Hematology-OncologyPhiladelphia-positive ALLChemotherapy-free

Ponatinib Plus Blinatumomab vs. Imatinib And Chemotherapy: Advancing Frontline Therapy in Adult Philadelphia-Positive ALL

By MedXY|Oct 21, 2026

This phase 3 trial demonstrates that a chemotherapy-free regimen combining ponatinib and blinatumomab significantly improves event-free survival over imatinib plus chemotherapy in adults with Philadelphia chromosome-positive acute lymphobla

Health Status Impairments in Tyrosine Kinase Inhibitor-Treated Chronic Myeloid Leukemia Patients Compared with Blood or Marrow Transplant Survivors and Non-Cancer Controls: A Clinical Review
Clinical Updates
blood or marrow transplantation
Chất ức chế kinase tyrosine

Health Status Impairments in Tyrosine Kinase Inhibitor-Treated Chronic Myeloid Leukemia Patients Compared with Blood or Marrow Transplant Survivors and Non-Cancer Controls: A Clinical Review

By MedXY|Aug 23, 2026

This review synthesizes evidence on health status impairments in long-term TKI-treated CML survivors relative to BMT survivors and non-cancer controls, emphasizing rates of functional impairment, activity limitation, frailty, and quality of

Strategic Sequencing of Systemic Therapies in Advanced Hepatocellular Carcinoma: Beyond the Second Line
GastroenterologyChất ức chế kinase tyrosinehepatocellular carcinoma

Strategic Sequencing of Systemic Therapies in Advanced Hepatocellular Carcinoma: Beyond the Second Line

By MedXY|Jun 28, 2026

This article reviews evolving therapeutic sequences in advanced hepatocellular carcinoma, highlighting the integration of immune-based combinations, tyrosine kinase inhibitors, liver function preservation, and the emerging multidimensional

Unraveling Molecular Mechanisms in Chronic Myeloid Leukemia: Insights from the EURO-SKI Biomarker Study on Treatment-Free Remission and Relapse
Hematology-OncologyChất ức chế kinase tyrosinemolecular biomarkers

Unraveling Molecular Mechanisms in Chronic Myeloid Leukemia: Insights from the EURO-SKI Biomarker Study on Treatment-Free Remission and Relapse

By MedXY|Jun 25, 2026

The EURO-SKI Biomarker Study elucidates molecular signatures and immune interactions underlying treatment-free remission and relapse in chronic myeloid leukemia patients discontinuing tyrosine kinase inhibitors, highlighting immune communic

Optimizing CML Management: Clinical Synthesis of the ASC4OPT Study and the Allosteric Inhibition Paradigm
Clinical UpdatesAsciminibbệnh huyết học

Optimizing CML Management: Clinical Synthesis of the ASC4OPT Study and the Allosteric Inhibition Paradigm

By MedXY|Apr 27, 2026

This review synthesizes the ASC4OPT trial results alongside pivotal evidence from the ASCEMBL and ASC4FIRST studies, evaluating the role of the STAMP inhibitor asciminib in chronic myeloid leukemia across multiple treatment lines.

Ribosome Collisions and the ZAK-Dependent Ribotoxic Stress Response: A Novel Therapeutic Vulnerability in Chronic Myeloid Leukemia
Clinical UpdatesChất ức chế kinase tyrosineRibosome Collisions

Ribosome Collisions and the ZAK-Dependent Ribotoxic Stress Response: A Novel Therapeutic Vulnerability in Chronic Myeloid Leukemia

By MedXY|Apr 3, 2026

This review synthesizes evidence that BCR::ABL1 inhibitors induce ribosome collisions and ZAK-dependent apoptosis, highlighting the ribotoxic stress response as a critical pathway for TKI efficacy and a potential target to overcome resistan

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models